Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases - PubMed (original) (raw)

Review

Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases

Patrick Provost. Aging (Albany NY). 2010.

Abstract

Generated by the ribonuclease III Dicer, microRNAs (miRNAs) are predicted to regulate up to 90% of the genes in humans, suggesting that they may control every cellular processes in all cells and tissues of the human body! Likely to play a central role in health and disease, a dysfunctional miRNA-based regulation of gene expression may represent the main etiologic factor underlying age-related diseases affecting major organs, such as the brain. Here, we discuss some of the limitations associated to the interpretation and applicability of miRNA data, based on our recent study on the etiology of Alzheimer's disease (AD). Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD. However, whether miRNA data can be extrapolated and transposed to the human context of age-related diseases, such as AD, not only requires caution, but also warrants several considerations.

PubMed Disclaimer

Conflict of interest statement

The author of this manuscript has no conflict of interest to declare.

Similar articles

• MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
  Provost P. Provost P. Brain Res. 2010 Jun 18;1338:58-66. doi: 10.1016/j.brainres.2010.03.069. Epub 2010 Mar 27. Brain Res. 2010. PMID: 20347722 Free PMC article. Review.
• MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
  Liu CG, Wang JL, Li L, Wang PC. Liu CG, et al. Int J Mol Med. 2014 Jul;34(1):160-6. doi: 10.3892/ijmm.2014.1780. Epub 2014 May 13. Int J Mol Med. 2014. PMID: 24827165
• Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
  Liu H, Tian T, Qin S, Li W, Zhang X, Wang X, Gao Y, Huang G. Liu H, et al. J Nutr Biochem. 2015 Dec;26(12):1502-8. doi: 10.1016/j.jnutbio.2015.07.020. Epub 2015 Aug 8. J Nutr Biochem. 2015. PMID: 26345540
• miR-186 is decreased in aged brain and suppresses BACE1 expression.
  Kim J, Yoon H, Chung DE, Brown JL, Belmonte KC, Kim J. Kim J, et al. J Neurochem. 2016 May;137(3):436-45. doi: 10.1111/jnc.13507. Epub 2016 Mar 30. J Neurochem. 2016. PMID: 26710318 Free PMC article.
• MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease.
  Schonrock N, Matamales M, Ittner LM, Götz J. Schonrock N, et al. Exp Neurol. 2012 Jun;235(2):447-54. doi: 10.1016/j.expneurol.2011.11.013. Epub 2011 Nov 16. Exp Neurol. 2012. PMID: 22119426 Review.

Cited by

• Real-time heterogeneity of supramolecular assembly of amyloid precursor protein is modulated by an endocytic risk factor PICALM.
  Belapurkar V, Mahadeva Swamy HS, Singh N, Kedia S, Setty SRG, Jose M, Nair D. Belapurkar V, et al. Cell Mol Life Sci. 2023 Sep 20;80(10):295. doi: 10.1007/s00018-023-04939-w. Cell Mol Life Sci. 2023. PMID: 37726569 Free PMC article.
• Epigenetics in Alzheimer's Disease.
  Gao X, Chen Q, Yao H, Tan J, Liu Z, Zhou Y, Zou Z. Gao X, et al. Front Aging Neurosci. 2022 Jun 23;14:911635. doi: 10.3389/fnagi.2022.911635. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35813941 Free PMC article. Review.
• Mechanisms Underlying Dysregulation of miR-132 in Alzheimer's Disease.
  Song Q, Dou J, Mao Z, Wen Z, Li W. Song Q, et al. Biomed J Sci Tech Res. 2019;22(5):17018-17020. doi: 10.26717/bjstr.2019.22.003824. Epub 2019 Nov 15. Biomed J Sci Tech Res. 2019. PMID: 35308096 Free PMC article. No abstract available.
• Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer's Disease.
  La Rosa F, Mancuso R, Agostini S, Piancone F, Marventano I, Saresella M, Hernis A, Fenoglio C, Galimberti D, Scarpini E, Clerici M. La Rosa F, et al. Pharmaceuticals (Basel). 2021 Nov 20;14(11):1187. doi: 10.3390/ph14111187. Pharmaceuticals (Basel). 2021. PMID: 34832969 Free PMC article.
• Cytotoxic and estrogenic activity of chlorpyrifos and its metabolite 3,5,6-trichloro-2-pyridinol. Study of marine yeasts as potential toxicity indicators.
  Echeverri-Jaramillo G, Jaramillo-Colorado B, Sabater-Marco C, Castillo-López MÁ. Echeverri-Jaramillo G, et al. Ecotoxicology. 2021 Jan;30(1):104-117. doi: 10.1007/s10646-020-02315-z. Epub 2020 Nov 29. Ecotoxicology. 2021. PMID: 33249537

References

1. 1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233. - PMC - PubMed
2. 1. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006;126:1203–1217. - PubMed
3. 1. Perron MP, Boissonneault V, Gobeil LA, Ouellet DL, Provost P. Regulatory RNAs: future perspectives in diagnosis, prognosis, and individualized therapy. Methods Mol Biol. 2007;361:311–326. - PMC - PubMed
4. 1. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430:631–639. - PMC - PubMed
5. 1. Mucke L. Neuroscience: Alzheimer's disease. Nature. 2009;461:895–897. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Impact Journals, LLC
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information